Company Analysis
Sign in

STAAR Surgical Company (STAA)

Nasdaq: STAA · Ophthalmic Goods · Monrovia, CA · filing with the SEC since 1995
Full chart Alerts Compare
Grade3.4
◀ Past 3.5● Present 3.5▶ Future 3.0
1 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart
The companyfiscal 2026, as filed
Revenue$239M-23.7%
Net income-$80.4M-298.1%
Earnings per share$-1.62-295.1%
Operating cash flow-$34.2M-317.7%
Cash$153M+6.2%
Debtn/a
Shareholders’ equity$344M-13.4%
Shares, diluted49.6M+0.9%
Return on equity-23.4%
The recordfrom its filings
Filings in 202666
Newest filingNov 4 · 10-Q
Annual reportMar 3, 2026
Quarterly reportNov 4, 2026
Next report due10-K by Mar 3
Insider sales, 12 months$0.00
Insider buys, 12 months$50.5M
Patents granted71
Filer categoryLarge accelerated filer
Trailing twelve months to Oct 2026Revenue $328MNet income $530,000Cash from operations $21.4Mthe four newest filed quarters added
Left: the newest annual report, with the change on the year before. Right: counted from the company's own filings with the SEC.
Revenue and net income by fiscal yearRevenueNet income
161718202122232426
As filed, in USD. Nothing here is a forecast.

News

Nov 4, 2026 · SEC EDGAR · Form 10-Q
Quarterly report
Open the filing on sec.gov
Nov 4, 2026 · SEC EDGAR · Form 8-K
Results released
Open the filing on sec.gov
Sep 10, 2026 · SEC EDGAR · Form 8-K
Current report
Open the filing on sec.gov
Aug 18, 2026 · SEC EDGAR · Form 4
Insider trade report
Open the filing on sec.gov
Aug 18, 2026 · SEC EDGAR · Form 4
Insider trade report
Open the filing on sec.gov
Aug 18, 2026 · SEC EDGAR · Form 4
Insider trade report
Open the filing on sec.gov
Aug 12, 2026 · SEC EDGAR · Form 10-Q
Quarterly report
Open the filing on sec.gov
An outside story is shown by its headline, its source and its link only. The SI reads the page when you ask it to break one down.
SI Assistanton STAA · research, not advice